Zobrazeno 1 - 10
of 17
pro vyhledávání: '"John Z. Liang"'
Autor:
Rong-Cheng Li, Li-Rong Huang, Xin Zhou, Peter C. Giardina, John Z. Liang, Shunping Mo, Junchun Li, Mariano Young, Zhangjing Chen, Daniel A. Scott
Publikováno v:
Vaccine. 33(30):3580-3585
BackgroundThis postlicensure study was conducted to assess immunogenicity and safety of PCV7 catch-up regimens in previously unvaccinated older infants and young children in China.MethodsHealthy children 121 days to 90% of subjects had IgG≥0.35μg/
Autor:
Olubukola T. Idoko, Robert B. Mboizi, Michael Okoye, France Laudat, Bubacarr Ceesay, John Z. Liang, Natacha Le Dren-Narayanin, Kathrin U. Jansen, Alejandra Gurtman, Kimberly J. Center, Daniel A. Scott, Beate Kampmann, Anna Roca
Background This open-label randomized controlled trial in infants compared safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) formulated with the preservative 2-phenoxyethanol (2-PE) in a multidose vial (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92cc10bd56ef54ff6ce0b193204a918
https://researchonline.lshtm.ac.uk/id/eprint/4650139/1/Idoko_etal_2017_Immunogenicity-and-safety-of-13-valent-pneumococcal-conjugate-vaccine.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4650139/1/Idoko_etal_2017_Immunogenicity-and-safety-of-13-valent-pneumococcal-conjugate-vaccine.pdf
Publikováno v:
SID Symposium Digest of Technical Papers. 44:1163-1166
The direct mechanical touching usually generates mura on a LCD panel. The touch mura cannot always be flashed in a very short period. Touch mura exists in almost every mode of LCD. In this paper, a new type of mura which generated during the LCD modu
Autor:
Zhangjing Chen, Daniel A. Scott, Bing Yan, John Z. Liang, Hu Yuemei, Fengcai Zhu, Qiang Ye, Jingxin Li, Xin Zhou, Peter C. Giardina, William C. Gruber, Mariano M. Young
Publikováno v:
The Pediatric infectious disease journal. 35(9)
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) were compared with 7-valent pneumococcal conjugate vaccine (PCV7) in Chinese infants.Healthy infants aged 2 months were randomized to a double-blind 3-dose infant series pl
Autor:
Mariano Young, John Z. Liang, Hu Yuemei, Fengcai Zhu, Zhangjing Chen, Xin Zhou, Daniel A. Scott, Liang Qi, William C. Gruber
Publikováno v:
Therapeutic advances in drug safety. 6(6)
Objective: Pneumococcal disease is a global problem, including in China. The objective of this study was to provide safety data for single-dose 13-valent pneumococcal conjugate vaccine (PCV13) in Chinese subjects, needed to begin a phase III safety a
Autor:
Pilar Infante-Marquez, Peter C. Giardina, Federico Martinón-Torres, Javier Díez-Domingo, Alejandra Gurtman, Emilio A. Emini, Alfonso Delgado, John Z. Liang, Valentin Pineda-Solas, William C. Gruber, Francisco Gimenez-Sanchez, Enrique Bernaola, Daniel A. Scott
Publikováno v:
Vaccine. 31(46)
Background Given the concurrent administration of multiple vaccines during routine pediatric immunizations, efforts to elucidate the potential interference of any vaccine on the immune response to the concomitantly administered antigens are fundament
Autor:
Francisco, Gimenez-Sanchez, Dorothee M, Kieninger, Kathrin, Kueper, Federico, Martinon-Torres, Enrique, Bernaola, Javier, Diez-Domingo, Kathrin, Steul, Christine, Juergens, Alejandra, Gurtman, Peter, Giardina, John Z, Liang, William C, Gruber, Emilio A, Emini, Daniel A, Scott, Johannes, Zimmer
Publikováno v:
Vaccine. 29(35)
Two randomized trials of 13-valent pneumococcal conjugate vaccine (PCV13) relative to PCV7 evaluated the immune responses of coadministered antigens comprising Infanrix(®) hexa/Infanrix(®)-IPV+Hib (diphtheria, tetanus, 3-component acellular pertuss
Autor:
Ahmad Razmpour, Susanna Esposito, A Maida, Emilio A. Emini, Susan P. Tansey, Daniel A. Scott, Giuseppe Ferrera, Gianni Bona, Nicola Principi, John Z. Liang, C. Sabatini, Lorenza Pugni, Thomas R. Jones, Allison Thompson, William C. Gruber
A 13-valent pneumococcal conjugate vaccine (PCV13) has been developed to improve protection against pneumococcal disease beyond that possible with the licensed 7-valent vaccine (PCV7). This study compared the safety and immunogenicity of PCV13 with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ae8533699e8f20a5df656f4b2b7847
http://hdl.handle.net/11391/1417744
http://hdl.handle.net/11391/1417744
Autor:
Pittman, Debra D., Carrieri, Charles, Soares, Holly, McKay, John, Tan, Charles Y., Liang, John Z., Rakhe, Swapnil, Marshall, Jean-Claude, Murphy, John E., Gaitonde, Puneet, Rupon, Jeremy
Publikováno v:
Thrombosis & Haemostasis; Oct2024, Vol. 124 Issue 10, p912-921, 10p
Autor:
John Z. Liang, Kong-Xiong Fang, Mariano Young, Xin Zhou, Peter C. Giardina, Zhangjing Chen, Daniel A. Scott, Rong-Cheng Li
Publikováno v:
Vaccine. (44):5359-5365
Background In a previous study, Chinese infants were vaccinated with 7-valent pneumococcal conjugate vaccine (PCV7) ⩾7 days before routine diphtheria, tetanus, and acellular pertussis vaccine (DTaP); PCV7 administered concomitantly with DTaP (PCV7